The Battle of the mRNA Coronavirus Vaccine Makers

Brian Orelli, PhD, The Motley Fool
·5-min read

Messenger RNA (mRNA) is a new class of drugs that involves injecting mRNA that code for specific proteins into a patient and letting the patient's cells make the protein. In this video from Motley Fool Live recorded on November 23, Corinne Cardina, bureau chief of healthcare and cannabis, and Brian Orelli, contributor, discuss how the technology can be used to create vaccines and the differences between the vaccine candidates that are under review by the Food and Drug Administration. Corinne Cardina: Let's back up a little bit and look at the data that we got over the past couple of weeks from Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA).